Risk factors and prognosis of interstitial lung disease for primary Sjogren syndrome patients: A retrospective case-control study

被引:1
|
作者
Huang, Yichen [1 ]
Qiu, Yanran [1 ]
Xie, Zhijun [2 ]
Zhang, Fengqi [2 ]
Zhang, Yi [2 ]
Guan, Meihui [1 ]
Wang, Xinchang [1 ]
Cai, Wanru [1 ]
Sun, Jing [1 ]
机构
[1] Zhejiang Chinese Med Univ, Clin Coll 2, Hangzhou, Zhejiang, Peoples R China
[2] Zhejiang Chinese Med Univ, Sch Basic Med Sci, Hangzhou, Zhejiang, Peoples R China
关键词
Case-control study; Interstitial lung disease; Primary Sjogren syndrome; Risk factor; MORTALITY; CLASSIFICATION; UPDATE;
D O I
10.1007/s10067-023-06596-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To determine the prevalence, clinical features, risk factors, and prognosis of interstitial lung disease (ILD) in patients with primary Sjogren's syndrome (pSS).Methods Data from 274 pSS patients from August 2013 to August 2022 were reviewed. The clinical features of pSS with ILD were revealed. Logistic regression was used to determine risk factors for ILD in pSS patients. Survival analysis and Cox regression were used to analyse the prognosis and prognostic factors of pSS patients.Results In pSS patients, the prevalence of ILD was 22.3% (61/274). The pSS patients with ILD were characterized by a late onset and long disease course, with a nonspecific interstitial pneumonia (NSIP) pattern as the predominant high-resolution computed tomography (HRCT) finding. Logistic regression results indicated that an age over 50 years old (OR 4.786, 95% CI 1.602-14.299; P = 0.005), purpuric rash (OR 4.695, 95% CI 1.537-14.339; P = 0.007), AMA-M2 antibody positivity (OR 2.582, 95% CI 1.166-5.722; P = 0.019), and diabetes (OR 2.514, 95% CI 1.025-6.167; P = 0.044) were risk factors for ILD in pSS patients. Cox regression results showed that advanced age (HR 1.240, 95% CI 1.088-1.413; P = 0.001) and cancer history (HR 8.411, 95% CI 1.771-39.934; P = 0.007) were risk factors for pSS patient survival.Conclusion This study showed that pSS patients with ILD tended to have a late onset and long course of pSS. An age over 50 years, purpuric rash, AMA-M2 antibody positivity, and diabetes were risk factors for ILD in pSS patients. Advanced age and cancer history were prognostic factors in pSS patients.
引用
收藏
页码:3033 / 3041
页数:9
相关论文
共 50 条
  • [41] Prognostic Significance of Autoantibody Positivity in Interstitial Lung Disease: A Retrospective Case-Control Study
    Kampolis, Christos F.
    Venetsanopoulou, Aliki I.
    Karakontaki, Fotini
    Polychronopoulos, Vlassis
    Vlachoyiannopoulos, Panayiotis G.
    Tzioufas, Athanasios G.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [42] Interstitial lung disease in patients with antisynthetase syndrome: a retrospective case series study
    Elisa Baratella
    Cristina Marrocchio
    Rossella Cifaldi
    Mario Santagiuliana
    Alessandro Marco Bozzato
    Paola Crivelli
    Barbara Ruaro
    Francesco Salton
    Marco Confalonieri
    Maria Assunta Cova
    Japanese Journal of Radiology, 2021, 39 : 40 - 46
  • [43] Interstitial lung disease in patients with antisynthetase syndrome: a retrospective case series study
    Baratella, Elisa
    Marrocchio, Cristina
    Cifaldi, Rossella
    Santagiuliana, Mario
    Bozzato, Alessandro Marco
    Crivelli, Paola
    Ruaro, Barbara
    Salton, Francesco
    Confalonieri, Marco
    Cova, Maria Assunta
    JAPANESE JOURNAL OF RADIOLOGY, 2021, 39 (01) : 40 - 46
  • [44] Fibromyalgia in Mexican patients with primary Sjogren's syndrome. A case-control study
    Hinojosa-Perez, E.
    Gomez-Guerrero, M. R.
    de La Torre, I. Garcia
    Riebeling-Navarro, C.
    Nava, A.
    Orozco-Barocio, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 473 - 474
  • [45] Increased prevalence of zinc hypersensitivity in patients with primary Sjogren syndrome: A case-control study
    Kageyama, Yasunari
    Aida, Koichi
    Nishizaki, Yasuhiro
    Ebisui, Tomoka
    Akiyama, Tetsu
    Nakamura, Tsutomu
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2024, 27 (01)
  • [46] Pregnancy outcome in patients with primary Sjogren's syndrome.: A case-control study
    Haga, HJ
    Gjesdal, CG
    Koksvik, HS
    Skomsvoll, JF
    Irgens, LM
    Östensen, M
    JOURNAL OF RHEUMATOLOGY, 2005, 32 (09) : 1734 - 1736
  • [47] The Use of Antidepressants and the Risk of Interstitial Lung Disease (ILD) in Patients with Respiratory Disease: A Nested Case-Control Study
    Lapi, Francesco
    Kezouh, Abbas
    Saad, Natalie
    Suissa, Samy
    Ernst, Pierre
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 438 - 439
  • [48] INTERSTITIAL LUNG DISEASE IN PRIMARY SJOGREN SYNDROME: A GESSAR ANALISYS
    Velez, S. D.
    Zazzetti, F.
    Galvan, L. S.
    Gallacher, A.
    Mayer, M.
    Rivero, M.
    Gomez, A.
    Marina, K. C.
    Duartes Noe, D.
    Busamia, B.
    Caeiro, F.
    Encinas, L.
    Pucci, P.
    Amitrano, C.
    Asnal, C.
    Nitsche, A.
    Santiago, L.
    Tamborenea, N.
    Salvatierra, G.
    Papasidero, S.
    Gauna, M.
    Oliver, M.
    Raiti, L.
    Secco, A.
    Laborde, H. A.
    Rilla, O.
    Catalan Pellet, A.
    Barreira, J. C.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 186 - 186
  • [49] XEROTRACHEA AND INTERSTITIAL LUNG-DISEASE IN PRIMARY SJOGREN SYNDROME
    CONSTANTOPOULOS, SH
    DROSOS, AA
    MADDISON, PJ
    MOUTSOPOULOS, HM
    RESPIRATION, 1984, 46 (03) : 310 - 314
  • [50] Risk of drug-induced interstitial lung disease in hospitalised patients: a nested case-control study
    Jo, Taisuke
    Michihata, Nobuaki
    Yamana, Hayato
    Morita, Kojiro
    Ishimaru, Miho
    Yamauchi, Yasuhiro
    Hasegawa, Wakae
    Urushiyama, Hirokazu
    Uda, Kazuaki
    Matsui, Hiroki
    Fushimi, Kiyohide
    Yasunaga, Hideo
    Nagase, Takahide
    THORAX, 2021, 76 (12) : 1193 - 1199